INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
Public company

ADVMAdverum Biotechnologies, Inc.

CIK 0001501756

EDGAR filingsOpen in network
Disclosed transactions40
Buys / sells1 / 0
Max Insider Score44
Connections7with evidence

ADVM · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
HS
Hong SooDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
4,000 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 5, 2026
  • ← Insider ofevidence
    Hong SooDirector · Dec 10, 2025
  • ← Insider ofevidence
    Seyedkazemi SetarehCHIEF DEVELOPMENT OFFICER · Dec 10, 2025
  • ← Insider ofevidence
    Kiss SzilardDirector · Dec 10, 2025
9
LL
Lupher, Jr. Mark L.Director
ADVMAdverum Biotechnologies, Inc.
Tender of shares
U
—
13.0K sh
Dec 9, 2025
Dec 10, 2025
traded Dec 9, 2025
+1d
SEC FORM 4

Evidence

9
KS
Kiss SzilardDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
1,250 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
KS
Kiss SzilardDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
2,000 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
KS
Kiss SzilardDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
8,000 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
KS
Kiss SzilardDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
4,500 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
KS
Kiss SzilardDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
2,500 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
KS
Kiss SzilardDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
2,500 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
HS
Hong SooDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
8,000 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
HS
Hong SooDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
10.5K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
HS
Hong SooDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
10.4K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
SS
Seyedkazemi SetarehCHIEF DEVELOPMENT OFFICER
ADVMAdverum Biotechnologies, Inc.
Tender of shares
U—
54.9K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
SS
Seyedkazemi SetarehCHIEF DEVELOPMENT OFFICER
ADVMAdverum Biotechnologies, Inc.
Tender of shares
U—
8,125 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

21
SS
Seyedkazemi SetarehCHIEF DEVELOPMENT OFFICER
ADVMAdverum Biotechnologies, Inc.
Grant or award
A—
85.0K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
SS
Seyedkazemi SetarehCHIEF DEVELOPMENT OFFICER
ADVMAdverum Biotechnologies, Inc.
Tender of shares
U—
88.3K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
SS
Seyedkazemi SetarehCHIEF DEVELOPMENT OFFICER
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
40.0K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
SS
Seyedkazemi SetarehCHIEF DEVELOPMENT OFFICER
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
42.5K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
SS
Seyedkazemi SetarehCHIEF DEVELOPMENT OFFICER
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
8,500 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
SS
Seyedkazemi SetarehCHIEF DEVELOPMENT OFFICER
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
25.0K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
SS
Seyedkazemi SetarehCHIEF DEVELOPMENT OFFICER
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
43.5K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
SS
Seyedkazemi SetarehCHIEF DEVELOPMENT OFFICER
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
48.8K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
OG
Ozden Rabia GursesChief Medical Officer
ADVMAdverum Biotechnologies, Inc.
Tender of shares
U—
8,125 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
OG
Ozden Rabia GursesChief Medical Officer
ADVMAdverum Biotechnologies, Inc.
Grant or award
A—
85.0K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
OG
Ozden Rabia GursesChief Medical Officer
ADVMAdverum Biotechnologies, Inc.
Tender of shares
U—
85.0K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
OG
Ozden Rabia GursesChief Medical Officer
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
8,000 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
OG
Ozden Rabia GursesChief Medical Officer
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
4,000 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
OG
Ozden Rabia GursesChief Medical Officer
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
85.0K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
OG
Ozden Rabia GursesChief Medical Officer
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
44.0K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
OG
Ozden Rabia GursesChief Medical Officer
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
48.8K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
LL
Lupher, Jr. Mark L.Director
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
7,000 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
LL
Lupher, Jr. Mark L.Director
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
4,500 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
LL
Lupher, Jr. Mark L.Director
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
3,000 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
LL
Lupher, Jr. Mark L.Director
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
4,000 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
LL
Lupher, Jr. Mark L.Director
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
4,000 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
LL
Lupher, Jr. Mark L.Director
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
10.5K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
LL
Lupher, Jr. Mark L.Director
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
10.4K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
KS
Kiss SzilardDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
21.0K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
LL
Lupher, Jr. Mark L.Director
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
4,000 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
KS
Kiss SzilardDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
10.4K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

44
SP
Soparkar PeterCHIEF OPERATING OFFICER
ADVMAdverum Biotechnologies, Inc.
Open-market purchase
BUY$211K
50.0K sh
Dec 5, 2025Dec 8, 2025
traded Dec 5, 2025
+3dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Lupher, Jr. Mark L.Director · Dec 10, 2025
  • ← Insider ofevidence
    Ozden Rabia GursesChief Medical Officer · Dec 10, 2025
  • ← Insider ofevidence
    Soparkar PeterCHIEF OPERATING OFFICER · Dec 8, 2025
    • Source error

    Price history for ADVM is unavailable.

    An error occurred in the Server Components render. The specific message is omitted in production builds to avoid leaking sensitive details. A digest property is included on this error instance which may provide additional details about the nature of the error.